SCHEMBL4371692

SCHEMBL4371692

CCCCCCCC/C=C\CCCCCCCC(=O)C(CCC(=O)O)(C(=O)O)C(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.65
▸ PPARD Q03181 5/20 0.65
▸ PPARA Q07869 5/20 0.65
▸ F7 P08709 5/20 0.65
▸ F3 P13726 5/20 0.65
▸ TERT O14746 3/20 0.65
▸ PTPN1 P18031 3/20 0.65
▸ HSD17B10 Q99714 3/20 0.65
▸ FABP4 P15090 3/20 0.65
▸ TOP1 P11387 3/20 0.65
▸ MAPT P10636 2/20 0.65
▸ BLM P54132 2/20 0.65
▸ LMNA P02545 2/20 0.65
▸ ALOX15 P16050 2/20 0.65
▸ DUSP3 P51452 2/20 0.65
▸ CYP19A1 P11511 2/20 0.65
▸ PTGS1 P23219 2/20 0.65
▸ NR4A2 P43354 2/20 0.65
▸ SIRT6 Q8N6T7 2/20 0.65
▸ PTPN7 P35236 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4371696 1.00 PPARG (0.65) PPARGPPARDPPARAF7F3
Adipic Acid SCHEMBL28790872 0.93 PPARG (0.68) PPARGPPARDPPARAF7F3
SCHEMBL3418506 0.91 FAAH (0.61) PPARGPPARDPPARAF7F3
SCHEMBL3422826 0.91 FAAH (0.61) PPARGPPARDPPARAF7F3
SCHEMBL3421715 0.91 FAAH (0.61) PPARGPPARDPPARAF7F3
SCHEMBL31481970 0.91 FAAH (0.61) PPARGPPARDPPARAF7F3
SCHEMBL5332704 0.87 ALDH1A1 (0.62) PPARGPPARDPPARAF7F3
SCHEMBL1758737 0.87 FAAH (0.56) PPARGPPARDPPARAF7F3
SCHEMBL1758741 0.87 FAAH (0.56) PPARGPPARDPPARAF7F3
SCHEMBL3420628 0.86 FAAH (0.63) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150110713-A1 METHOD AND COMPOSITION FOR TREATING CANCER MANGANARO ANTHONY (US) 2015-04-23 — — US claimed
US-20120164065-A1 METHOD AND COMPOSITION FOR TREATING CANCER MANGANARO ANTHONY (US) 2012-06-28 — — US claimed
WO-2008112565-A9 METHOD AND COMPOSITION FOR TREATING CANCER ROCKWELL KAREN (US) 2009-02-19 — — WO claimed
US-20080279764-A1 METHOD AND COMPOSITION FOR TREATING CANCER Manganaro, Anthony (US) 2008-11-13 — — US claimed
WO-2008112565-A2 METHOD AND COMPOSITION FOR TREATING CANCER MANGANARO ANTHONY (US) 2008-09-18 — — WO claimed
WO-2005110363-A2 SYSTEMS AND METHODS FOR PREPARATION OF PHARMACEUTICAL DOSAGE USING COMPOSITIONS CONTAINING AQUEOUS VESICLES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2005-11-24 — — WO claimed
US-20050232973-A1 Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2005-10-20 — — US claimed
US-20150110713-A1 METHOD AND COMPOSITION FOR TREATING CANCER MANGANARO ANTHONY (US) 2015-04-23 — — US disclosed
US-20120164065-A1 METHOD AND COMPOSITION FOR TREATING CANCER MANGANARO ANTHONY (US) 2012-06-28 — — US disclosed
WO-2008112565-A9 METHOD AND COMPOSITION FOR TREATING CANCER ROCKWELL KAREN (US) 2009-02-19 — — WO disclosed
US-20080279764-A1 METHOD AND COMPOSITION FOR TREATING CANCER Manganaro, Anthony (US) 2008-11-13 — — US disclosed
WO-2008112565-A2 METHOD AND COMPOSITION FOR TREATING CANCER MANGANARO ANTHONY (US) 2008-09-18 — — WO disclosed
WO-2005110363-A2 SYSTEMS AND METHODS FOR PREPARATION OF PHARMACEUTICAL DOSAGE USING COMPOSITIONS CONTAINING AQUEOUS VESICLES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2005-11-24 — — WO disclosed
US-20050232973-A1 Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2005-10-20 — — US disclosed
Send feedback